UGRP1 (Uteroglobin-Related Protein 1) is a member of the secretoglobin family, involved in various biological processes including inflammation modulation, immune response regulation, and possibly tissue repair. Its expression is noted in mucosal linings, suggesting a role in barrier functions and the body's defense mechanisms against pathogens and environmental insults. The precise mechanisms of UGRP1 activation remain to be fully elucidated, but it is known to be influenced by the cellular microenvironment, including inflammatory status, oxidative stress, and signaling cascades that regulate cellular metabolism and differentiation.
Functional activation of UGRP1 is critical for its role in maintaining mucosal integrity and modulating immune responses. Given the lack of direct chemical activators, the activation mechanisms may involve indirect pathways through which cellular signaling molecules influence UGRP1 activity. These pathways include those regulated by cyclic AMP (cAMP), protein kinase A (PKA), nuclear factor (erythroid-derived 2)-like 2 (Nrf2), and peroxisome proliferator-activated receptors (PPARs), among others. Activation of these pathways can lead to alterations in cellular processes such as inflammation, oxidative stress response, and metabolism, creating a conducive environment for UGRP1 activation. For instance, agents that elevate intracellular cAMP levels can indirectly enhance UGRP1 activity by activating PKA, which may phosphorylate regulatory proteins involved in UGRP1's function or expression. Similarly, compounds that activate Nrf2 could indirectly support UGRP1's role in cellular defense mechanisms by upregulating antioxidant response elements.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased cAMP levels. Elevated cAMP promotes PKA activation, which could enhance UGRP1 activity by phosphorylating proteins involved in its regulation or trafficking. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX, a non-specific inhibitor of phosphodiesterases, prevents cAMP breakdown, synergizing with agents like Forskolin to elevate cAMP and activate PKA, potentially enhancing UGRP1 activity through downstream signaling pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid influences cellular differentiation and proliferation. Through its receptor-mediated action, it can modulate signaling pathways that may upregulate UGRP1 activity by altering the cellular context or expression of regulatory proteins. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
A cAMP analog that is resistant to degradation by phosphodiesterases, directly stimulating PKA activation. This activation can lead to changes in cellular signaling cascades that indirectly activate UGRP1 by modulating its regulatory mechanisms. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG can modulate multiple signaling pathways, including those related to inflammation and oxidative stress. By modulating these pathways, EGCG could create a cellular environment that indirectly activates UGRP1. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane activates the Nrf2 pathway, which is involved in cellular responses to oxidative stress. Activation of Nrf2 could indirectly promote UGRP1 activity by enhancing cellular defenses and possibly influencing UGRP1 regulatory mechanisms. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates SIRT1, which is involved in cellular stress responses and longevity. SIRT1 activation could indirectly influence UGRP1 activity through deacetylation of proteins that regulate UGRP1 or its signaling pathways. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
As a PPARγ agonist, Pioglitazone modulates lipid metabolism and insulin sensitivity. It could indirectly activate UGRP1 by altering metabolic status and signaling pathways related to metabolism that intersect with UGRP1's regulation. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin, a flavonoid, modulates various signaling pathways, including those related to antioxidant responses and inflammation. These modulations could indirectly activate UGRP1 by affecting cellular stress responses or regulatory proteins. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin activates AMPK, a key regulator of cellular energy status. AMPK activation could indirectly activate UGRP1 by influencing cellular metabolism and signaling pathways that intersect with the regulation of UGRP1. | ||||||